Lijuan Xu

Lijuan Xu

PhD Student


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2023
  2. Published

    A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology

    Xu, Lijuan, Henriksen, C., Mebus, Viktor Hundtofte, Guérillot, R., Petersen, A., Jacques, N., Jiang, J. H., Derks, R. J. E., Sánchez-López, E., Giera, M., Leeten, K., Stinear, T. P., Oury, C., Howden, B. P., Peleg, A. Y. & Frees, Dorte, 2023, In: Antimicrobial Agents and Chemotherapy. 67, 6, 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2020
  4. Published

    The sle1 cell wall amidase is essential for β-lactam resistance in community-acquired methicillin-resistant staphylococcus aureus USA300

    Thalsø-Madsen, I., Torrubia, F. R., Xu, Lijuan, Petersen, A., Jensen, C. & Frees, Dorte, 2020, In: Antimicrobial Agents and Chemotherapy. 64, 1, 15 p., e01931-19.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2019
  6. Published

    The ClpX chaperone controls autolytic splitting of Staphylococcus aureus daughter cells, but is bypassed by β-lactam antibiotics or inhibitors of WTA biosynthesis

    Jensen, C., Bæk, K. T., Gallay, C., Thalsø-Madsen, I., Xu, Lijuan, Jousselin, A., Ruiz Torrubia, F., Paulander, W., Pereira, A. R., Veening, J. W., Pinho, M. G. & Frees, Dorte, 2019, In: PLOS Pathogens. 15, 9, 27 p., e1008044.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 201653149